Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1300 |
---|---|
Product Name | Anti-Human ERBB3 Recombinant Antibody(Seribantumab) |
Molecular Name | Seribantumab |
Alias | Anti-ERBB3 Recombinant Antibody, Research Grade Seribantumab |
CAS Number | 1334296-12-6 |
Target | ERBB3[Homo sapiens] |
Isotype | IgG2 Lambda |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, ICC |
Buffer | PBS, pH7.5 |
Background | Seribantumab (INN, development code MM-121) is a monoclonal antibody designed for the treatment of cancer. This drug was developed by Sanofi/Merrimack Pharmaceuticals, Inc. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |